Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Tarsus Pharmaceuticals, Inc. (TARS)

74.85 +0.65 (+0.88%)
At close: October 30 at 4:00:00 PM EDT
75.55 +0.70 (+0.94%)
After hours: October 30 at 4:34:30 PM EDT
Trade TARS on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
606,331
451,360
182,953
17,447
25,816
Cost of Revenue
40,745
30,684
12,826
1,593
955
Gross Profit
565,586
420,676
170,127
15,854
24,861
Operating Expense
614,121
491,645
290,696
159,012
87,573
Operating Income
-48,535
-70,969
-120,569
-143,158
-62,712
Net Non Operating Interest Income Expense
6,718
6,812
7,165
6,991
1,300
Other Income Expense
2,468
-202
-2,150
274
-683
Pretax Income
-39,349
-64,359
-115,554
-135,893
-62,095
Tax Provision
7,127
2,059
0
0
-4
Net Income Common Stockholders
-46,476
-66,418
-115,554
-135,893
-62,091
Diluted NI Available to Com Stockholders
-46,476
-66,418
-115,554
-135,893
-62,091
Basic EPS
-1.07
-1.59
-3.07
-4.62
-2.52
Diluted EPS
-1.07
-1.59
-3.07
-4.62
-2.52
Basic Average Shares
42,937.59
41,784.01
37,604.54
29,383.28
24,619.70
Diluted Average Shares
42,937.59
41,784.01
37,604.54
29,383.28
24,619.70
Total Operating Income as Reported
-48,535
-70,969
-120,569
-143,158
-62,712
Total Expenses
654,866
522,329
303,522
160,605
88,528
Net Income from Continuing & Discontinued Operation
-46,476
-66,418
-115,554
-135,893
-62,091
Normalized Income
-48,163.20
-66,418
-113,610
-135,893
-61,322.05
Interest Income
15,484
15,747
15,014
10,337
3,499
Interest Expense
8,133
8,342
7,447
3,225
2,064
Net Interest Income
6,718
6,812
7,165
6,991
1,300
EBIT
-31,216
-56,017
-108,107
-132,668
-60,031
EBITDA
-28,876
-54,201
-106,882
-131,791
-59,705
Reconciled Cost of Revenue
40,745
30,684
12,826
1,593
955
Reconciled Depreciation
2,340
1,816
1,225
877
326
Net Income from Continuing Operation Net Minority Interest
-46,476
-66,418
-115,554
-135,893
-62,091
Total Unusual Items Excluding Goodwill
2,812
0
-1,944
0
-769
Total Unusual Items
2,812
0
-1,944
0
-769
Normalized EBITDA
-31,688
-54,201
-104,938
-131,791
-58,936
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,124.80
0
0
0
-0.05
12/31/2022 - 10/16/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: